Operations Management

Slides:



Advertisements
Similar presentations
Industry Trends and Tools for Generic Product Selection KATE KUHRT SHANGHAI JUNE 19-21, 2007.
Advertisements

Critical Success Factors for the Korean Generic and API Industry in a post FTA Environment DAVID HARDING SEOUL JUNE 28-29, 2007.
The Top 10 List – Best Lessons Learned from FDA Warning Letters Walter Nowocin Medtronic, Inc./Minneapolis, Minnesota Measurement Science Conference 23.
Hale & Tempest India Biotech Briefing Dr. Brian W Tempest IBIZ Conference, NHS Expo Excel London UK 9 March 2011.
Regulatory Update Ellen Leinfuss SVP, Life Sciences.
What is Food Recall A food recall is a voluntary action by a manufacturer or distributor to protect the public from products that may cause health problems.
Granules India Corporate Presentation
DAVID HARDING MARCH 12, 2008 DCAT WEEK PERCEPTIONS vs. REALITY Facts and Figures on the Generic Industry.
Veiovis LifeSciences Pvt Ltd
Hale & Tempest India UKIBC Briefing Dr. Brian W Tempest UK India Business Council Manchester 10 March 2011.
1 Hosting an FDA Inspection: A Field Investigator ’ s Perspective Presented by Mihaly S. Ligmond Consumer Safety Officer US Food and Drug Administration,
ERM and the Pharmaceutical Industry. Risk  An innate part of every aspect of life, and the business environment is of no exception  Severity, both in.
U.S. Blood Banking Industry Food and Drug Administration (FDA) Regulations Limit Donor Pool, Multiply Costs "In an effort to curtail the spread of mad.
Thomas Eingle, R.Ph. Inpatient Pharmacy Supervisor James A. Haley Veterans Hospital, Tampa, Fl.
Sophie Wilkinson Bayer Pharmaceuticals Case Study.
Good Manufacturing Practices – A Regulatory Perspective Presented By: Ashok Kumar Dua Plant Head – Unichem Laboratories (Sikkim )
Indian Clinical Trials- The Unaddressed Challenges of Regulatory Amendments Dr. N. Srinivas Principal Malla Reddy Institute of Pharmaceutical Sciences.
References: Supply Chain Saves the World. Boston, MA: AMR Research (2006); Designing and Managing the Supply Chain – Concepts, Strategies and Case Studies;
Dr. Shilpa Bhilegaonkar Total Quality Management and Quality Risk Management.
FDA's New Enforcement of 21 CFR Part 11
Important Points The pharmaceutical industry in India ranks 3rd in the world terms of volume and 14th in terms of value.India’s cost of production is.
Marketing Management Dr. Aravind Banakar –
Operation Management Dr. Aravind Banakar –
Marketing Management Dr. Aravind Banakar –
Operations Management Dr. Aravind Banakar –
International Business Dr. Aravind Banakar –
International Business Dr. Aravind Banakar –
Essential of Management Dr. Aravind Banakar –
Human Resource Management Dr. Aravind Banakar –
Project Management Dr. Aravind Banakar –
International Business Dr. Aravind Banakar –
International Business Dr. Aravind Banakar –
International Business Dr. Aravind Banakar –
International Business Dr. Aravind Banakar –
International Business Dr. Aravind Banakar –
International Business Dr. Aravind Banakar –
International Business Dr. Aravind Banakar –
This presentation uses a free template provided by FPPT.com Operation Management Dr. Aravind Banakar –
Principles and Practice of Management Dr. Aravind Banakar –
International Business Dr. Aravind Banakar –
Project Management Dr. Aravind Banakar –
This presentation uses a free template provided by FPPT.com Marketing Management Dr. Aravind Banakar –
Marketing Management Dr. Aravind Banakar –
Business Strategy
International Business
Business Strategy
Operations Management
International Business
Operations Management
International Business
International Business
International Business
International Business
Operations Management
Operations Management
International Business
International Business
International Business
International Business
International Business
International Business
International Business
International Business
Marketing Management
Marketing Management
© Coherent market Insights. All Rights Reserved Premium Cosmetics Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS,
סמים וסינפסות.
A Strategic Transition ( )
GMP Inspection Process
Presentation transcript:

Operations Management

Operations Management Case Studies case study (20 Marks) In 2011,, the chairman of Dr. Reddy’s Laboratories (DRL) had just had his morning coffee, when he received the news that US Food and Drug Administration (USFDA) had imposed an import ban on products manufactured at DRL’s Mexico plant for violation of good manufacturing practice norms. DRL’s Mexican arm, which the company bought from Swiss pharmaceutical major Roche in 2005, produced intermediates and Active Pharmaceutical Ingredients (APIs). After going through the letter twice, Prasad was convinced that he had to take immediate corrective actions.

Though the company had taken some corrective actions following the warning letter and also replied back to the USFDA, it faced this ban. As Prasad looked back at the fond memories following the acquisition in 2005, he wondered what went wrong at the Mexico plant and how could he address them without upsetting the current stakeholders of DRL. The case focuses on the problems faced by Dr. Reddy’s Laboratories (DRL), a leading Indian pharmaceutical company, with respect to its Mexico plant in The company had acquired the plant, which supplied these bulk drugs to other pharmaceutical companies in the West, from Roche. DRL received a warning letter from the US drug regulator, USFDA, for violating current good manufacturing practices.

USFDA inspected the plant and found it non-compliant with the manufacturing practice norms for APIs. The FDA sought an answer from DRL within 15 days of the letter. Though the company managed to submit a report to the USFDA within the stipulated time, a ban was imposed on the import of products from the Mexico plant as USFDA was not satisfied with the company’s response.

Answer the following question. Q1. Explain the link between strategy and operations. Q2. Discuss the issues and challenges in quality management. Q3. Discuss the issues and challenges for a company from an emerging market competing in the global markets, particularly markets in the West. Q4. Explain the importance of operational effectiveness in sustaining a low cost strategy.